Abstract
Advanced drug delivery systems present indubitable advantages for drug administration. During the past three decades, new approaches for the development of new carriers for this topic have been suggested. This led to explosion of publication activity in the area. This article reviews briefly the history of the topic and focuses on general concepts in the issue. One of the most crucial properties of advanced delivery systems is their ability to be well controlled in terms of a carrier structure which is responsible for an optimal drug release. Here we describe new polymerization technologies which consider this particular aspect. A special attention is paid to the preparation of materials by LRP (Living Radical Polymerization) and perspectives of its practical application to the treatment of single diseases. Due to the epidemic scale of Diabetes mellitus, novel drug delivery systems play an important role in and are highly relevant for improved treatment of worldwide permanently growing sub-population of diabetic patients. Type 1 is the insulin-dependent diabetes which accounts for 5 till 10 percent of the whole pool of diabetic cases and currently attracts main attention in research activity devoted to the development of advanced drug delivery systems. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease.
Keywords: Living radical polymerization, drug delivery systems, cells encapsulation, Diabetes mellitus
Infectious Disorders - Drug Targets
Title: New Approaches in Drug Delivery Systems: Application for Diabetes Treatment
Volume: 8 Issue: 2
Author(s): Jorge F. J. Coelho, Paula Ferreira and Maria H. Gil
Affiliation:
Keywords: Living radical polymerization, drug delivery systems, cells encapsulation, Diabetes mellitus
Abstract: Advanced drug delivery systems present indubitable advantages for drug administration. During the past three decades, new approaches for the development of new carriers for this topic have been suggested. This led to explosion of publication activity in the area. This article reviews briefly the history of the topic and focuses on general concepts in the issue. One of the most crucial properties of advanced delivery systems is their ability to be well controlled in terms of a carrier structure which is responsible for an optimal drug release. Here we describe new polymerization technologies which consider this particular aspect. A special attention is paid to the preparation of materials by LRP (Living Radical Polymerization) and perspectives of its practical application to the treatment of single diseases. Due to the epidemic scale of Diabetes mellitus, novel drug delivery systems play an important role in and are highly relevant for improved treatment of worldwide permanently growing sub-population of diabetic patients. Type 1 is the insulin-dependent diabetes which accounts for 5 till 10 percent of the whole pool of diabetic cases and currently attracts main attention in research activity devoted to the development of advanced drug delivery systems. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease.
Export Options
About this article
Cite this article as:
Coelho F. J. Jorge, Ferreira Paula and Gil H. Maria, New Approaches in Drug Delivery Systems: Application for Diabetes Treatment, Infectious Disorders - Drug Targets 2008; 8 (2) . https://dx.doi.org/10.2174/187152608784746556
DOI https://dx.doi.org/10.2174/187152608784746556 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index to Volume 1
Current Alzheimer Research Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma
Current Medicinal Chemistry Factors Affecting Residual Platelet Aggregation in Prasugrel Treated Patients
Current Pharmaceutical Design Optimization and Validation of a Microscale In vitro Method to Assess α-Glucosidase Inhibition Activity
Current Analytical Chemistry Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Mini-Reviews in Medicinal Chemistry Pharmacogenetics Strategies: From Candidate Genes to Whole-Genome Association Analysis. Exploratory or Confirmatory Studies?
Current Pharmacogenomics and Personalized Medicine Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?
Current Pharmaceutical Design Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews Comparative Proteomics of Liver of the Diabetic Obese db/db and Non-Obese or Diabetic Mice
Current Proteomics Tissue Doppler Imaging: Beautiful Noise
Current Cardiology Reviews Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Xenobiotic-CoA Ligases: Kinetic and Molecular Characterization
Current Drug Metabolism The Insulin-sensitizing Role of the Fat Derived Hormone Adiponectin
Current Pharmaceutical Design Insights into the Platelet Releasate
Current Pharmaceutical Design Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets
Reviews on Recent Clinical Trials Pharmacological Management of Diabetic Nephropathy
Current Vascular Pharmacology New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Simvastatin and Other HMG-CoA Reductase Inhibitors on Brain Cholesterol Levels in Alzheimers Disease
Current Alzheimer Research Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants
Endocrine, Metabolic & Immune Disorders - Drug Targets